NeuroTrials.ai The Neurology Trials Database
About Contact
Trials Latest Wiki Journal Evidence
AI-Powered Neurology Evidence Search

Oncology Trials

June 2026 · 5 Trials · NeuroTrials.ai
FEATURED ARTICLE
Does intraoperative radiotherapy delivered to the resection cavity provide effective local control and acceptable safety in patients with newly diagnosed brain metastases?

INTRAMET

Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET)

Journal of Neuro-Oncology · 2026

Bottom Line: Low-energy X-ray IORT (30 Gy at the applicator surface) delivered to the resection cavity at the time of brain metastasis resection achieved a 94.3% local control rate at 1 and 2 years with no grade 4/5 IORT-related toxicities, suggesting it may be a feasible alternative to postoperative stereotactic radiosurgery in…

BRAIN METASTASES 3

Does stereotactic radiation provide better patient-reported outcomes than hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases?

SRS vs HA-WBRT for Brain Metastases

2026

In patients with 5 to 20 brain metastases, does stereotactic radiation targeting individual tumors reduce symptom burden and interference with daily function compared with hippocampal-avoidance whole brain radiation?

HipSter

2026

Does intraoperative radiotherapy delivered to the resection cavity provide effective local control and acceptable safety in patients with newly diagnosed brain metastases?

INTRAMET

2026

THERAPEUTICS 2

Can a CDK4/6 inhibitor shrink or stabilize progressive meningiomas harboring NF2 or CDK pathway mutations?

Alliance A071401

2026

Does oncolytic herpes virus treatment reprogram the glioblastoma immune microenvironment to enable T cell-mediated tumor killing?

rQNestin GBM

2026

Oncolytic Virus for Recurrent Glioblastoma โ€” Spatial Omics Analysis